文献速递骨肌介入神经DSA

经皮骶骨成形术联合或不联合射频消融治疗疼痛性骶骨转移瘤

Percutaneous Sacroplasty with or without Radiofrequency Ablation for Treatment of Painful Sacral Metastases.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-07-21

回顾性纳入2012年10月至2021年2月共126例患者(162处疼痛性骶骨转移灶),比较经皮骶骨成形术联合射频消融(A组51例)与单纯经皮骶骨成形术(B组75例)的疗效与安全性。两组视觉模拟量表、Oswestry功能障碍指数和Karnofsky功能状态评分均显著改善(P<.05),A组总体疼痛缓解率显著优于B组(90%对76%,P=.032),两组及四种入路间骨水泥渗漏发生率无显著差异(P>.05)。作者认为两者均安全有效,联合射频消融似乎更有效。

要点

  • 疼痛性骶骨转移瘤可行经皮骶骨成形术,联合射频消融组总体疼痛缓解率90%,优于单纯成形术组76%(P=.032)。
  • 两组治疗后视觉模拟量表、Oswestry功能障碍指数和Karnofsky功能状态评分均显著改善(P<.05)。
  • 两组间及经髂骨、椎弓根间、前斜位、后侧四种入路间骨水泥渗漏发生率均无显著差异(P>.05)。

核心结论

  • 单纯经皮骶骨成形术及经皮骶骨成形术联合射频消融治疗疼痛性骶骨转移瘤均安全有效,联合射频消融似乎比单纯经皮骶骨成形术更有效。

研究设计与样本

  • 回顾性研究,2012年10月至2021年2月纳入126例患者共162处疼痛性骶骨转移灶。
  • A组51例接受经皮骶骨成形术联合射频消融,B组75例接受单纯经皮骶骨成形术。
  • 经皮骶骨成形术采用经髂骨、椎弓根间、前斜位和后侧四种入路。
  • 采用视觉模拟量表、Oswestry功能障碍指数和Karnofsky功能状态评分评估疗效,并在透视引导下操作。

诊断标准与关键数值

  • A组总体疼痛缓解率90% vs B组76%,A组显著优于B组(P=.032)。
  • 两组治疗后视觉模拟量表、Oswestry功能障碍指数和Karnofsky功能状态评分均显著改善(P<.05)。
  • 两组间及四种入路间聚甲基丙烯酸甲酯渗漏发生率均无显著差异(P>.05)。

临床应用与阅片要点

  • 对无病理性骨折的疼痛性骶骨转移瘤,可考虑经皮骶骨成形术,联合射频消融可能获得更高的总体疼痛缓解率。
  • 术中可采用经髂骨、椎弓根间、前斜位或后侧入路,不同入路间骨水泥渗漏发生率无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Percutaneous sacroplasty is a variation of percutaneous vertebroplasty that has gained attention as a therapeutic option for patients with painful sacral insufficiency fractures due to osteoporosis or metastases. Additionally, percutaneous sacroplasty can also be used to treat painful sacral metastases without a pathologic fracture. The purpose of this retrospective study was to compare the efficacy and safety of fluoroscopy-guided percutaneous sacroplasty alone versus percutaneous sacroplasty plus radiofrequency ablation for the treatment of painful sacral metastases.

MATERIALS AND METHODS: For this retrospective study, 126 patients (with a total of 162 painful sacral metastases) were enrolled from October 2012 to February 2021 and assigned to receive either percutaneous sacroplasty plus radiofrequency ablation (n = 51, group A) or percutaneous sacroplasty alone (n = 75, group B). Four different approaches were used for percutaneous sacroplasty: transiliac, interpedicular, anterior-oblique, and posterior. The Visual Analog Scale, Oswestry Disability Index, and Karnofsky Performance Scale were used to evaluate outcomes.

RESULTS: The Visual Analog Scale, Oswestry Disability Index, and Karnofsky Performance Scale scores showed significant improvement in both groups after treatment (P < .05). The overall pain relief rate was significantly better in group A than in group B (90% versus 76%, P = .032). There were no significant differences in the incidence of polymethylmethacrylate leakage between the 2 groups or among the 4 different approaches (P > .05).

CONCLUSIONS: Both percutaneous sacroplasty alone and the combination of percutaneous sacroplasty and radiofrequency ablation are safe and effective for treatment of painful sacral metastases. The combination of percutaneous sacroplasty and radiofrequency ablation appears to be more effective than percutaneous sacroplasty alone.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Tian, -Han, Wang, et al. Percutaneous Sacroplasty with or without Radiofrequency Ablation for Treatment of Painful Sacral Metastases. AJNR Am J Neuroradiol. 2022. PMID: 35863777. doi:10.3174/ajnr.A7587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。